190 related articles for article (PubMed ID: 37316763)
1. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
[TBL] [Abstract][Full Text] [Related]
2. STAT6 gain-of-function variant exacerbates multiple allergic symptoms.
Takeuchi I; Yanagi K; Takada S; Uchiyama T; Igarashi A; Motomura K; Hayashi Y; Nagano N; Matsuoka R; Sugiyama H; Yoshioka T; Saito H; Kawai T; Miyaji Y; Inuzuka Y; Matsubara Y; Ohya Y; Shimizu T; Matsumoto K; Arai K; Nomura I; Kaname T; Morita H
J Allergy Clin Immunol; 2023 May; 151(5):1402-1409.e6. PubMed ID: 36538978
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
[TBL] [Abstract][Full Text] [Related]
4. Activating STAT6 mutations in follicular lymphoma.
Yildiz M; Li H; Bernard D; Amin NA; Ouillette P; Jones S; Saiya-Cork K; Parkin B; Jacobi K; Shedden K; Wang S; Chang AE; Kaminski MS; Malek SN
Blood; 2015 Jan; 125(4):668-79. PubMed ID: 25428220
[TBL] [Abstract][Full Text] [Related]
5. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond.
;
Trends Immunol; 2024 Feb; 45(2):138-153. PubMed ID: 38238227
[TBL] [Abstract][Full Text] [Related]
6. A germline STAT6 gain-of-function variant is associated with early-onset allergies.
Suratannon N; Ittiwut C; Dik WA; Ittiwut R; Meesilpavikkai K; Israsena N; Ingrungruanglert P; Dalm VASH; van Daele PLA; Sanpavat A; Chaijitraruch N; Schrijver B; Buranapraditkun S; Porntaveetus T; Swagemakers SMA; IJspeert H; Palaga T; Suphapeetiporn K; van der Spek PJ; Hirankarn N; Chatchatee P; Martin van Hagen P; Shotelersuk V
J Allergy Clin Immunol; 2023 Feb; 151(2):565-571.e9. PubMed ID: 36216080
[TBL] [Abstract][Full Text] [Related]
7. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.
Sharma M; Leung D; Momenilandi M; Jones LCW; Pacillo L; James AE; Murrell JR; Delafontaine S; Maimaris J; Vaseghi-Shanjani M; Del Bel KL; Lu HY; Chua GT; Di Cesare S; Fornes O; Liu Z; Di Matteo G; Fu MP; Amodio D; Tam IYS; Chan GSW; Sharma AA; Dalmann J; van der Lee R; Blanchard-Rohner G; Lin S; Philippot Q; Richmond PA; Lee JJ; Matthews A; Seear M; Turvey AK; Philips RL; Brown-Whitehorn TF; Gray CJ; Izumi K; Treat JR; Wood KH; Lack J; Khleborodova A; Niemela JE; Yang X; Liang R; Kui L; Wong CSM; Poon GWK; Hoischen A; van der Made CI; Yang J; Chan KW; Rosa Duque JSD; Lee PPW; Ho MHK; Chung BHY; Le HTM; Yang W; Rohani P; Fouladvand A; Rokni-Zadeh H; Changi-Ashtiani M; Miryounesi M; Puel A; Shahrooei M; Finocchi A; Rossi P; Rivalta B; Cifaldi C; Novelli A; Passarelli C; Arasi S; Bullens D; Sauer K; Claeys T; Biggs CM; Morris EC; Rosenzweig SD; O'Shea JJ; Wasserman WW; Bedford HM; van Karnebeek CDM; Palma P; Burns SO; Meyts I; Casanova JL; Lyons JJ; Parvaneh N; Nguyen ATV; Cancrini C; Heimall J; Ahmed H; McKinnon ML; Lau YL; Béziat V; Turvey SE
J Exp Med; 2023 May; 220(5):. PubMed ID: 36884218
[TBL] [Abstract][Full Text] [Related]
8. PARP14 is a novel target in STAT6 mutant follicular lymphoma.
Mentz M; Keay W; Strobl CD; Antoniolli M; Adolph L; Heide M; Lechner A; Haebe S; Osterode E; Kridel R; Ziegenhain C; Wange LE; Hildebrand JA; Shree T; Silkenstedt E; Staiger AM; Ott G; Horn H; Szczepanowski M; Richter J; Levy R; Rosenwald A; Enard W; Zimber-Strobl U; von Bergwelt-Baildon M; Hiddemann W; Klapper W; Schmidt-Supprian M; Rudelius M; Bararia D; Passerini V; Weigert O
Leukemia; 2022 Sep; 36(9):2281-2292. PubMed ID: 35851155
[TBL] [Abstract][Full Text] [Related]
9. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Wei W; Song Z; Yang Y
Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
[TBL] [Abstract][Full Text] [Related]
10. STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology.
Karpathiou G; Papoudou-Bai A; Ferrand E; Dumollard JM; Peoc'h M
Pathol Res Pract; 2021 Jul; 223():153477. PubMed ID: 33991851
[TBL] [Abstract][Full Text] [Related]
11. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6.
Baris S; Benamar M; Chen Q; Catak MC; Martínez-Blanco M; Wang M; Fong J; Massaad MJ; Sefer AP; Kara A; Babayeva R; Eltan SB; Yucelten AD; Bozkurtlar E; Cinel L; Karakoc-Aydiner E; Zheng Y; Wu H; Ozen A; Schmitz-Abe K; Chatila TA
J Allergy Clin Immunol; 2023 Jul; 152(1):182-194.e7. PubMed ID: 36758835
[TBL] [Abstract][Full Text] [Related]
12. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
[TBL] [Abstract][Full Text] [Related]
13. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells.
So EY; Oh J; Jang JY; Kim JH; Lee CE
Mol Immunol; 2007 Jul; 44(13):3416-26. PubMed ID: 17433443
[TBL] [Abstract][Full Text] [Related]
14. Impaired IL-4 phosphorylation of STAT6 in EBV transformed B-cells.
Poritz LS; Zhang WJ; Thompson J; Boyer M; Clark C; Koltun WA
J Surg Res; 2010 Aug; 162(2):290-8. PubMed ID: 19540524
[TBL] [Abstract][Full Text] [Related]
15. IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathway.
Liu Y; Zhang H; Ni R; Jia WQ; Wang YY
Pulm Pharmacol Ther; 2017 Apr; 43():32-38. PubMed ID: 28093225
[TBL] [Abstract][Full Text] [Related]
16. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.
Miloudi H; Leroy K; Jardin F; Sola B
Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729
[TBL] [Abstract][Full Text] [Related]
17. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
[TBL] [Abstract][Full Text] [Related]
18. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
[TBL] [Abstract][Full Text] [Related]
19. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
Ritz O; Rommel K; Dorsch K; Kelsch E; Melzner J; Buck M; Leroy K; Papadopoulou V; Wagner S; Marienfeld R; Brüderlein S; Lennerz JK; Möller P
Oncotarget; 2013 Jul; 4(7):1093-102. PubMed ID: 23852366
[TBL] [Abstract][Full Text] [Related]
20. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
